← All trials
NCT05003596
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2021
- Primary completion
- Aug 1, 2022
- Completion date
- Sep 1, 2023
- First posted
- Aug 12, 2021
- Last posted
- Aug 12, 2021
- Enrollment
- 60
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- St. Barnabas Medical Center, Livingston, NJLead sponsor
- Rutgers UniversityOverall official - principal investigator
- St. Barnabas Medical Center, Livingston, NJReponsible party - principal investigator
- Brielle OrthopedicsCollaborator
- University Orthopedics AssociatesCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.